Literature DB >> 32439398

The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma.

Yijie Wang1, Yufeng Xu1, Xizhe Dai1, Xiling Lin2, Yi Shan1, Juan Ye3.   

Abstract

Uveal melanoma (UM) is the most common primary intraocular malignancy in adults and has a high mortality rate. Tumor microenvironment (TME) is crucial in controlling and influencing the behavior of malignant tumors. Thus, illustrating the prognostic values of adaptive immune resistance signatures and infiltrating immune cells in the TME of UM may provide scientific rationales for immunotherapy. In this study, the gene expression data of 80 primary UM and 103 primary skin cutaneous melanoma (SKCM) samples with relevant clinical information were obtained from The Cancer Genome Atlas (TCGA) database. The TME was analyzed by the xCell, EPIC, ESTIMATE and TIMER algorithms. The relationships and prognostic values of immune infiltrates and mutated genes were further investigated. We found that primary UM and primary SKCM exhibited distinct TMEs. Higher levels of infiltrating stromal and immune cells in UM were related to more aggressive biology and poor prognosis. Increased CD8+ T cell level, as well as several adaptive immune resistance markers, was a predictive factor of poor prognosis in UM. Furthermore, some common mutations of UM were associated with its TME. This study analyzed the immune landscape of adaptive immune resistance signatures and infiltrating immune cells in the TME of UM. Identification of these immune-related biomarkers may thus enable the prediction of prognosis and the selection of optimal immunotherapy strategies in UM.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adaptive immune resistance; Infiltrating immune cells; Tumor microenvironment; Uveal melanoma

Year:  2020        PMID: 32439398     DOI: 10.1016/j.exer.2020.108069

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  10 in total

1.  Identification of molecular subtyping system and four-gene prognostic signature with immune-related genes for uveal melanoma.

Authors:  Fei Xia; Zhilong Yu; Aijun Deng; Guohong Gao
Journal:  Exp Biol Med (Maywood)       Date:  2021-11-07

Review 2.  Molecular Pathology of Skin Melanoma: Epidemiology, Differential Diagnostics, Prognosis and Therapy Prediction.

Authors:  József Tímár; Andrea Ladányi
Journal:  Int J Mol Sci       Date:  2022-05-11       Impact factor: 6.208

Review 3.  How to Make Immunotherapy an Effective Therapeutic Choice for Uveal Melanoma.

Authors:  Mariarosaria Marseglia; Adriana Amaro; Nicola Solari; Rosaria Gangemi; Elena Croce; Enrica Teresa Tanda; Francesco Spagnolo; Gilberto Filaci; Ulrich Pfeffer; Michela Croce
Journal:  Cancers (Basel)       Date:  2021-04-23       Impact factor: 6.639

4.  Expression, prognosis value, and immune infiltration of lncRNA ASB16-AS1 identified by pan-cancer analysis.

Authors:  Linyong Wu; Wei Liao; Xiaodong Wang; Yujia Zhao; Jinshu Pang; Yuji Chen; Hong Yang; Yun He
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

5.  Integrative analysis identifies key genes related to metastasis and a robust gene-based prognostic signature in uveal melanoma.

Authors:  Shizhen Lei; Yi Zhang
Journal:  BMC Med Genomics       Date:  2022-03-17       Impact factor: 3.063

6.  Landscape of Infiltrated Immune Cell Characterization in Uveal Melanoma to Improve Immune Checkpoint Blockade Therapy.

Authors:  Xiaohui Lv; Min Ding; Yan Liu
Journal:  Front Immunol       Date:  2022-03-02       Impact factor: 7.561

7.  Prognostic value of immune-related genes and comparative analysis of immune cell infiltration in lung adenocarcinoma: sex differences.

Authors:  Tao Fan; Chunxiang Li; Jie He
Journal:  Biol Sex Differ       Date:  2021-12-04       Impact factor: 5.027

8.  A Novel Four Genes of Prognostic Signature for Uveal Melanoma.

Authors:  Yan Liu; Huibin Du; Qi Wan; Yan He; Wei Lu; Wenhao Wang; Xiaohui Lv
Journal:  J Oncol       Date:  2022-04-05       Impact factor: 4.375

9.  Construction of a Promising Tumor-Infiltrating CD8+ T Cells Gene Signature to Improve Prediction of the Prognosis and Immune Response of Uveal Melanoma.

Authors:  Yifang Sun; Jian Wu; Yonggang Yuan; Yumin Lu; Ming Luo; Ling Lin; Shengsheng Ma
Journal:  Front Cell Dev Biol       Date:  2021-05-28

10.  Bioinformatic Analysis Reveals Central Role for Tumor-Infiltrating Immune Cells in Uveal Melanoma Progression.

Authors:  Mieszko Lachota; Anton Lennikov; Karl-Johan Malmberg; Radoslaw Zagozdzon
Journal:  J Immunol Res       Date:  2021-06-11       Impact factor: 4.818

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.